We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

Recent health updates include a rise in measles cases in Texas and New Mexico, expansion of Alnylam's heart disease drug ...

We recently published a list of Did Jim Cramer Get These 23 Stocks Right?. In this article, we are going to take a look at ...

The FDA's approval of Alnylam's heart disease drug expands treatment options in a market poised for growth. Meanwhile, the ...

They’re the faces we love to hate, or grew to love. The big players who graced our screens, radios and social media feeds – ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM) field, Alnylam is hoping its RNA ...

The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin ...

Pam Bondi vowed at her confirmation hearing this year that “politics will not play a part” in her time as attorney ...

It's officially spring, and as we move into this new season, there are plenty of opportunities to have fun with the whole ...

Despite advances in anticoagulant therapies, bleeding remains a critical concern.Traditionally, the definition of major ...

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That's one of several reasons ...